首页> 外文期刊>Supramolecular chemistry >Supramolecular approach for target transport of photodynamic anticancer agents
【24h】

Supramolecular approach for target transport of photodynamic anticancer agents

机译:超分子方法用于光动力抗癌药的靶标转运

获取原文
获取原文并翻译 | 示例
           

摘要

Photodynamic therapy (PDT) is one of the most modern methods for cancer therapy. Various types of advanced photosensitisers (PSs) have been developed for effective application in PDT. Current research has started to demonstrate the high importance of targeted PS transport and subcellular localisation for the effective destruction of tumours. Another possible approach for the improvement of PDT is the use of synergic PS for combination anticancer therapy. The implementation of a supramolecular approach is necessary for their effective design. This can be achieved through the use of PS as non-covalent complexes with suitable carriers such as human serum albumin, lectins, cyclodextrins, polysaccharides, lipoproteins, liposomes, intravenous immunoglobulins and polymeric micelles. In addition, some of these carriers have their own anticancer activity. An alternative approach can be the use of PS for the transport of other anticancer agents. Therefore, this minireview focuses on describing these supramolecular PS systems for targeted transport and combination therapy.
机译:光动力疗法(PDT)是最现代的癌症治疗方法之一。已经开发出各种类型的高级光敏剂(PS),以有效地应用于PDT。当前的研究已开始证明靶向PS转运和亚细胞定位对于有效破坏肿瘤的高度重要性。改善PDT的另一种可能方法是将协同PS用于联合抗癌治疗。超分子方法的实施对于它们的有效设计是必要的。这可以通过将PS与合适的载体(例如人血清白蛋白,凝集素,环糊精,多糖,脂蛋白,脂质体,静脉内免疫球蛋白和聚合胶束)作为非共价复合物使用来实现。另外,这些载体中的一些具有其自身的抗癌活性。替代方法可以是使用PS转运其他抗癌药。因此,本小型复习集中于描述这些用于靶向转运和联合治疗的超分子PS系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号